Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy

Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy

The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling marijuana.

President Trump Paves Way for Fewer Restrictions on Psychedelics

President Trump signed an executive order Saturday to expedite FDA reviews of psychedelic drugs to treat mental health disorders. The order, titled “Accelerating Medical Treatments for Serious Mental Illness,” purports to make experimental treatments for disorders like PTSD and depression more accessible to suffering citizens. Critics note the president’s directive doesn’t just facilitate research — it also creates a pathway for Schedule I psych…

Executive order on psychedelics ignores nonmedicinal use

Open the article to view the coverage from Chicago Sun Times